[Animal models and preclinical development of anti-osteoporosis drugs].
Ammann
P
P
Division des Maladies Osseuses, Centre Collaborateur de l'OMS pour l'Ostéoporose et les Maladies Osseuses, Département de Médecine Interne, Hôpital Universitaire, CH-1211 Genève 14, Suisse.
Rizzoli
R
R
Bonjour
J P
JP
D000818:Animals; D015415:Biomarkers; D001696:Biomechanical Phenomena; D015519:Bone Density; D016723:Bone Remodeling / Q000187:drug effects / Q000502:physiology; D004195:Disease Models, Animal; D004353:Drug Evaluation, Preclinical / Q000379:methods*; D006801:Humans; D051379:Mice; D010024:Osteoporosis / Q000175:diagnosis / Q000188:drug therapy* / Q000378:metabolism; D010599:Pharmacokinetics; D051381:Rats
D015415:Biomarkers